Search

Search Constraints

You searched for: Author/Creator Stenzig, Justus

Search Results

2. An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility. Issue 16 (20th October 2020)

3. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology. (April 2015)

5. Engineered heart tissue and optogenetics – A powerful and versatile combination. (31st December 2022)

6. Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes. (May 2021)

7. Pharmacokinetics of the Experimental Non‐Nucleosidic DNA Methyl Transferase Inhibitor N‐Phthalyl‐l‐Tryptophan (RG 108) in Rats. Issue 5 (8th December 2015)

8. Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats. (July 2018)

9. Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue. (February 2022)

10. Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling. Issue 23 (5th June 2018)